期刊
出版社
ELSEVIER SCIENCE BV
DOI: 10.1016/j.jchromb.2008.10.018
关键词
Antimalarial; Artesunate; Dihydroartemisinin; High throughput; Liquid chromatography/tandem mass spectrometry (LC-MS/MS); Stable isotope labeled (SIL) internal standard; Solid phase extraction (SPE)
资金
- US National Institute of Allergy and Infectious Diseases [NIH N01-AO-00042]
- Wellcome Trust of Great Britain [077166/Z/05/Z]
A bioanalytical method for the analysis of artesunate and its metabolite dihydroartemisinin in human plasma using high throughput solid-phase extraction in the 96-wellplate format and liquid chromatography coupled to positive tandem mass spectroscopy has been developed and validated. The method was validated according to published FDA guidelines and showed excellent performance. The within-clay and between-day precisions expressed as RSD, were lower than 7% at all tested concentrations including the lower limit of quantification. Using 50 mu l plasma the calibration range was 1.19-728 ng/ml with a limit of detection at 0.5 ng/ml for artesunate and 1.96-2500 ng/ml with a limit of detection at 0.6 ng/ml for dihydroartemisinin. Using 250 mu l of plasma sample the lower limit of quantification was decreased to 0.119 ng/ml for artesunate and 0.196 ng/ml dihydroartemisinin. Validation of over-curve samples in plasma ensured that accurate estimation Would be possible with dilution if samples went outside the calibration range. The method was free from matrix effects as demonstrated both graphically and quantitatively. (C) 2008 Elsevier B.V. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据